356 related articles for article (PubMed ID: 19944886)
21. What is the relationship between schizophrenia and substance abuse?
Green AI
Harv Ment Health Lett; 2000 Oct; 17(4):8. PubMed ID: 11015759
[No Abstract] [Full Text] [Related]
22. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.
Kim JH; Kim D; Park SH; Lee HB; Chung EK
J Nerv Ment Dis; 2007 Jul; 195(7):622-4. PubMed ID: 17632255
[TBL] [Abstract][Full Text] [Related]
23. Clinical challenges in the treatment of patients with posttraumatic stress disorder and substance abuse.
Schäfer I; Najavits LM
Curr Opin Psychiatry; 2007 Nov; 20(6):614-8. PubMed ID: 17921765
[TBL] [Abstract][Full Text] [Related]
24. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.
Cleghorn JM; Kaplan RD; Szechtman B; Szechtman H; Brown GM; Franco S
J Clin Psychiatry; 1991 Jan; 52(1):26-30. PubMed ID: 1671032
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.
Wobrock T; Soyka M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1375-85. PubMed ID: 18394768
[TBL] [Abstract][Full Text] [Related]
26. Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review.
De Witte NA; Crunelle CL; Sabbe B; Moggi F; Dom G
Eur Addict Res; 2014; 20(3):105-14. PubMed ID: 24192558
[TBL] [Abstract][Full Text] [Related]
27. Effect of substance misuse in early psychosis.
Addington J; Addington D
Br J Psychiatry Suppl; 1998; 172(33):134-6. PubMed ID: 9764140
[TBL] [Abstract][Full Text] [Related]
28. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
[TBL] [Abstract][Full Text] [Related]
29. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
30. A national study of violent behavior in persons with schizophrenia.
Swanson JW; Swartz MS; Van Dorn RA; Elbogen EB; Wagner HR; Rosenheck RA; Stroup TS; McEvoy JP; Lieberman JA
Arch Gen Psychiatry; 2006 May; 63(5):490-9. PubMed ID: 16651506
[TBL] [Abstract][Full Text] [Related]
31. Bipolar disorder and substance abuse.
Levin FR; Hennessy G
Biol Psychiatry; 2004 Nov; 56(10):738-48. PubMed ID: 15556118
[TBL] [Abstract][Full Text] [Related]
32. Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disorders.
Awad AG
Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):1-4. PubMed ID: 20121558
[No Abstract] [Full Text] [Related]
33. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
Thoma P; Daum I
Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
[TBL] [Abstract][Full Text] [Related]
34. Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients.
Krystal JH; D'Souza DC; Madonick S; Petrakis IL
Schizophr Res; 1999 Mar; 35 Suppl():S35-49. PubMed ID: 10190224
[TBL] [Abstract][Full Text] [Related]
35. Schizophrenia and co-occurring substance use disorder.
Green AI; Drake RE; Brunette MF; Noordsy DL
Am J Psychiatry; 2007 Mar; 164(3):402-8. PubMed ID: 17329463
[No Abstract] [Full Text] [Related]
36. Substance abuse and schizophrenia: pharmacotherapeutic intervention.
Green AI; Noordsy DL; Brunette MF; O'Keefe C
J Subst Abuse Treat; 2008 Jan; 34(1):61-71. PubMed ID: 17574793
[TBL] [Abstract][Full Text] [Related]
37. Treatment of substance use disorders with co-occurring severe mental health disorders.
Murthy P; Mahadevan J; Chand PK
Curr Opin Psychiatry; 2019 Jul; 32(4):293-299. PubMed ID: 31157674
[TBL] [Abstract][Full Text] [Related]
38. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
Arranz B; Garriga M; García-Rizo C; San L
Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
[TBL] [Abstract][Full Text] [Related]
39. Long-term Administration of Antipsychotic Drugs in Schizophrenia and Influence of Substance and Drug Abuse on the Disease Outcome.
Werner FM; Covenas R
Curr Drug Abuse Rev; 2017; 10(1):19-24. PubMed ID: 29065847
[TBL] [Abstract][Full Text] [Related]
40. Is it time to consider comorbid substance abuse as a new indication for antipsychotic drug development?
Awad AG
J Psychopharmacol; 2012 Jul; 26(7):953-7. PubMed ID: 22170735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
